Exchange: NASDAQ·Updated 03:59 PM EDT

IKNA Ikena Oncology Inc

$6.19
$0.20
(3.38%)
Today
Closed $6.12
$0.07
(1.14%)
After Hours
Reported EarningsAug 5
Mkt Cap$69.34M
Vol767.00

About IKNA

ImageneBio, Inc. is a clinical-stage biotechnology company that boldly imagines a world where patients can be free from the burden of grievous immunological/autoimmune and inflammatory (I&I) diseases. It focuses on the development of new medicines with differentiated profiles that can effectively control and change the course of I&I diseases for affected patients, treat their symptoms, and improve quality of life. The company was founded in February 2016, and is headquartered in San Diego, CA.
50

Neutral Sentiment

How do you feel about IKNA?

Advertisement|Remove ads.